|
|
|
Insider
Information: |
Robb Gary Charles |
Relationship: |
|
City: |
Menlo Park |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
20,203 |
|
Indirect Shares
|
25,100 |
|
|
Direct
Value |
$609,525 |
|
|
Indirect Value
|
$757,267 |
|
|
Total
Shares |
45,303 |
|
|
Total
Value |
$1,366,792 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
18
|
Stock
price went up :
|
0
|
12
|
Stock
price went down : |
0
|
6
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
61.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Corcept Therapeutics Inc |
CORT |
|
2024-05-28 |
20,203 |
2024-05-28 |
25,100 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
|
2021-01-22 |
4 |
OE |
$2.70 |
$1,220,000 |
D/D |
451,852 |
459,877 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
|
2021-01-22 |
4 |
D |
$28.06 |
$7,260,216 |
D/D |
(258,739) |
201,138 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2022-08-30 |
4 |
OE |
$2.08 |
$348,032 |
D/D |
167,323 |
191,446 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2021-08-30 |
4 |
OE |
$2.70 |
$400,000 |
D/D |
148,148 |
223,786 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
|
2021-02-12 |
4 |
S |
$28.22 |
$3,163,899 |
D/D |
(112,100) |
85,638 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2023-05-05 |
4 |
OE |
$1.92 |
$283,800 |
D/D |
105,000 |
124,583 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2022-08-30 |
4 |
D |
$26.14 |
$2,455,121 |
D/D |
(93,922) |
97,524 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2021-08-30 |
4 |
D |
$21.53 |
$1,742,595 |
D/D |
(80,938) |
142,848 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2023-05-05 |
4 |
D |
$24.07 |
$1,458,305 |
D/D |
(60,586) |
63,997 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2022-09-07 |
4 |
S |
$26.06 |
$1,303,000 |
D/D |
(50,000) |
49,544 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2021-09-15 |
4 |
S |
$20.49 |
$980,742 |
D/D |
(47,853) |
87,848 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2022-07-06 |
4 |
AS |
$26.00 |
$1,170,000 |
D/D |
(45,000) |
24,123 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2022-07-06 |
4 |
OE |
$2.08 |
$67,968 |
D/D |
32,677 |
69,123 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
|
2019-12-09 |
4 |
S |
$13.73 |
$412,029 |
D/D |
(30,000) |
8,025 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
|
2019-12-09 |
4 |
OE |
$1.92 |
$57,600 |
D/D |
30,000 |
38,025 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2023-05-09 |
4 |
S |
$23.87 |
$716,100 |
D/D |
(30,000) |
33,997 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2022-05-17 |
4 |
S |
$19.55 |
$561,965 |
D/D |
(28,745) |
42,701 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
|
2018-12-12 |
4 |
S |
$19.01 |
$475,153 |
D/D |
(25,000) |
6,858 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
|
2018-12-12 |
4 |
OE |
$1.92 |
$48,000 |
D/D |
25,000 |
21,858 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2023-12-04 |
4 |
OE |
$3.29 |
$49,350 |
D/D |
15,000 |
37,771 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2023-05-10 |
4 |
S |
$24.07 |
$336,980 |
D/D |
(14,000) |
19,997 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2023-09-14 |
4 |
OE |
$3.29 |
$45,938 |
D/D |
13,963 |
34,992 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2022-11-18 |
4 |
S |
$26.43 |
$354,188 |
D/D |
(13,401) |
26,143 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2024-05-28 |
4 |
AS |
$30.39 |
$334,294 |
D/D |
(11,000) |
20,203 |
0 |
% |
|
CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
|
2024-05-28 |
4 |
OE |
$3.29 |
$36,190 |
D/D |
11,000 |
31,203 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|